MCL

Div Dubey, M.B.B.S., explains Mayo Clinic Laboratories' phenotypic testing approach for autoimmune axonal neuropathy. The comprehensive, serologic panel detects for antibodies with clinical relevance to the disease to provide clarity on etiology, prognosis, and treatment choices.

In this episode of Lab Medicine Rounds, as we head into the holiday season, Justin Kreuter, M.D., and Andres Jaramillo, Ph.D., Associate Professor of Laboratory Medicine and Pathology at Mayo Clinic and director of the Histocompatibility Laboratory at Mayo Clinic’s Arizona campus, discuss the ultimate gift of organ transplantation.

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for December include the following sub-specialties: Clinical Informatics, Genitourinary Pathology, Hematopathology, Laboratory Genetics and Genomics, and Biochemical Genetics.

The quest to create a test pinpointing the source of the rare, testicular cancer-associated illness successfully concluded in the summer of 2021.

Starting December 7, you will notice enhancements to MayoClinicLabs.com. We are building a better website for you, our clients, to ensure the best experience possible. We’re moving toward a simpler, more intuitive and customized experience, making it easier to do business with us. 

While Gregor Heinrich never could have imagined that testicular cancer was related to his problems with his vision and gait, learning he was positive for KLHL11 protein biomarkers meant he could receive treatment for both the cancer and the illness behind it.

In this month's "Hot Topic," Jess Peterson, M.D., discusses changes to Mayo Clinic Laboratories’ hematology FISH menu to increase awareness, provide reasoning, and highlight some of the great things that are coming.

In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., and Thomas Grys, Ph.D., Associate Professor of Laboratory Medicine and Pathology in the Mayo Clinic College of Medicine and Science and co-director of Microbiology at Mayo Clinic’s Arizona campus, discuss valley fever testing and the importance of clinical context.

The following list includes updates posted to mayocliniclabs.com during the month of November.

Since being diagnosed with Graves’ disease, Ryan Black has come to know all too well the pain and discomfort of frequent blood draws. But rather than wallow in self-pity, the teen is spending her time trying to make blood draws easier and less painful for others like her. And she’s doing it with research from Mayo Clinic.

Michelle Kluge, M.S., CGC, explains how Mayo Clinic Laboratories’ CYPZ assay provides accurate testing for congenital adrenal hyperplasia. Using an in-depth methodology that incorporates Sanger sequencing, MCL can provide clear answers for carriers and individuals clinically affected by the most common form of CAH.

Starting mid-November, you will notice enhancements to MayoClinicLabs.com. We are building a better website for you, our clients, to ensure the best experience possible. We’re moving toward a simpler, more intuitive and customized experience, making it easier to do business with us.

Wei Shen, Ph.D., explains Mayo Clinic Laboratories' new expert-backed, hereditary oncology panels, which use next-generation sequencing to identify genetic mutations linked to increased cancer risk. By only including clinically significant genes, the panels provide clarity on diagnosis, prognosis, and treatment approaches.